Low incidence of TEL/AML1 fusion and TEL deletion in Korean childhood acute leukemia by extra-signal fluorescence in situ hybridization

被引:24
作者
Park, KU
She, CJ
Shin, HY
Ahn, HS
Kim, CJ
Cho, BK
Cho, HI
Lee, DS
机构
[1] Seoul Natl Univ, Coll Med, Dept Clin Pathol, Chongno Gu, Seoul 110744, South Korea
[2] Seoul Natl Univ, Coll Med, Dept Pediat, Chongno Gu, Seoul 110744, South Korea
[3] Seoul Natl Univ, Coll Med, Dept Pathol, Chongno Gu, Seoul 110744, South Korea
[4] Seoul Natl Univ, Coll Med, Dept Neurosurg, Chongno Gu, Seoul 110744, South Korea
关键词
D O I
10.1016/S0165-4608(00)00374-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
TEAL/AML1 fusion in acute leukemia results from cryptic translocation of chromosome 12 and 21, the presence of which suggests a favorable prognosis. The incidence of TEL/AML1 fusion in B-lineage ALL is approximately 25%, but the incidence in Korea has not yet been reported. To investigate the incidence of TEL/AML1 fusion and TEL deletion, bone marrow specimens from 77 Korean children with newly diagnosed acute leukemia were analyzed by FISH. We applied extra-signal FISH to discriminate a true TEL/AML1 fusion from a false-positive fusion signal. To determine the cut-off value of the TEL/AML1 fusion signal, 20 normal bone marrow specimens and 28 normal peripheral blood specimens were also analyzed. The frequency of patients with TEL/AML1 fusion was 13.3% (4 cases) among 30 B-lineage ALL and 9.5% among 42 ALL. One TEL/AML1 fusion-positive patient was also found among 4 acute biphenotypic leukemias. TEL/AML1 fusion was not found in any samples from patients with T-lineage ALL or AML. The incidence of TEL deletion was 6.7% (2 cases) among 30 B-lineage ALL and 4.8% among 42 ALL. The incidences of TEL/AML1 fusion and TEL deletion in Korean children with acute leukemia appear to be lower than those in other countries, suggesting a racial difference. (C) 2001 Elsevier Science Inc., All rights reserved.
引用
收藏
页码:73 / 77
页数:5
相关论文
共 24 条
  • [1] TEL-AML1 fusion in acute lymphoblastic leukaemia of adults
    Aguiar, RCT
    Sohal, J
    vanRhee, F
    Carapeti, M
    Franklin, IM
    Goldstone, AH
    Goldman, JM
    Cross, NCP
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1996, 95 (04) : 673 - 677
  • [2] Incidence and clinical relevance of TEL/AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicenter therapy trials
    Borkhardt, A
    Cazzaniga, G
    Viehmann, S
    Valsecchi, MG
    Ludwig, WD
    Burci, L
    Mangioni, S
    Schrappe, M
    Riehm, H
    Lampert, F
    Basso, G
    Masera, G
    Harbott, J
    Biondi, A
    [J]. BLOOD, 1997, 90 (02) : 571 - 577
  • [3] ETV6 is the target of chromosome 12p deletions in t(12;21) childhood acute lymphocytic leukemia
    Cave, H
    Cacheux, V
    Raynaud, S
    Brunie, G
    Bakkus, M
    Cochaux, P
    Preudhomme, C
    Lai, JL
    Vilmer, E
    Grandchamp, B
    [J]. LEUKEMIA, 1997, 11 (09) : 1459 - 1464
  • [4] Chase A, 1997, GENE CHROMOSOME CANC, V18, P246, DOI 10.1002/(SICI)1098-2264(199704)18:4<246::AID-GCC2>3.0.CO
  • [5] 2-0
  • [6] High frequency of acute promyelocytic leukemia among Latinos with acute myeloid leukemia
    Douer, D
    PrestonMartin, S
    Chang, E
    Nichols, PW
    Watkins, KJ
    Levine, AM
    [J]. BLOOD, 1996, 87 (01) : 308 - 313
  • [7] García-Sanz R, 1999, BRIT J HAEMATOL, V107, P667
  • [8] Inamdar N, 1998, INT J ONCOL, V13, P1319
  • [9] KOBAYASHI H, 1994, BLOOD, V84, P3473
  • [10] McLean TW, 1996, BLOOD, V88, P4252